Bactolife Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
52
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$35M
- Investors
-
7
Bactolife General Information
Description
Developer of proprietary binding protein ingredients designed to fortify the gut microbiome and reduce the risk of gastrointestinal infections in humans and animals. The company's platform focuses on neutralizing harmful pathogens and their toxins while preserving beneficial microbes, it aims to empower worldwide gut health and reduce dependence on antimicrobials to combat antimicrobial resistance, improving human and animal health through their innovative gut microbiome modulation technologies.
Contact Information
Website
www.bactolife.comCorporate Office
- Rønnegade 8, 2.
- 2100 Copenhagen
- Denmark
Corporate Office
- Rønnegade 8, 2.
- 2100 Copenhagen
- Denmark
Bactolife Timeline
Bactolife Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series B) | 06-Jan-2026 | $35M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series A) | 08-Aug-2023 | Completed | Generating Revenue | |||
| 4. Grant | 31-Aug-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 19-Apr-2021 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Jul-2020 | $2.02M | $2.02M | Completed | Generating Revenue | |
| 1. Grant | 01-Jan-2020 | $1.64M | Completed | Generating Revenue |
Bactolife Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 139,853 | $55.33 | $55.33 | 1x | $55.33 | |||
| Ordinary | 45,318 | $43.93 | $43.93 | 1x | $43.93 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Bactolife Comparisons
Industry
Financing
Details
Bactolife Competitors (1)
One of Bactolife’s competitors is Avilex Pharma, a Venture Capital-Backed company based in Copenhagen, Denmark.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Avilex Pharma | Venture Capital-Backed | Copenhagen, Denmark |
Bactolife Patents
Bactolife Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026185451-A1 | Single-domain antibody combined with butyrate for intestinal health improvement | Pending | 07-Mar-2025 | ||
| WO-2026131712-A1 | Single-domain antibody to reduce the risk of rotavirus a infection | Pending | 17-Dec-2024 | ||
| WO-2025228958-A1 | Single-domain antibodies to reduce the risk of cholera and e. coli infection | Pending | 30-Apr-2024 | ||
| WO-2024121125-A1 | Single-domain antibodies to reduce the risk of cholera infection | Inactive | 06-Dec-2022 | ||
| EP-4601745-A1 | Sdab-cbm fusion protein bound to polysaccharide polymer | Pending | 14-Oct-2022 | C07K16/12 |
Bactolife Signals
Bactolife Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cross Border Impact Ventures | Impact Investing | Minority | ||
| Denmark's Export and Investment Fund | Venture Capital | Minority | ||
| Athos (Family Office) | Family Office | Minority | ||
| Gates Foundation | Not-For-Profit Venture Capital | Minority | ||
| Novo Holdings | Venture Capital | Minority |
Bactolife FAQs
-
When was Bactolife founded?
Bactolife was founded in 2017.
-
Where is Bactolife headquartered?
Bactolife is headquartered in Copenhagen, Denmark.
-
What is the size of Bactolife?
Bactolife has 52 total employees.
-
What industry is Bactolife in?
Bactolife’s primary industry is Biotechnology.
-
Is Bactolife a private or public company?
Bactolife is a Private company.
-
What is Bactolife’s current revenue?
The current revenue for Bactolife is .
-
How much funding has Bactolife raised over time?
Bactolife has raised $79.1M.
-
Who are Bactolife’s investors?
Cross Border Impact Ventures, Denmark's Export and Investment Fund, Athos (Family Office), Gates Foundation, and Novo Holdings are 5 of 7 investors who have invested in Bactolife.
-
Who are Bactolife’s competitors?
Avilex Pharma is a competitor of Bactolife.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process